Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies.
Autore F, Tedeschi A, Benevolo G, Mattiello V, Galli E, Danesin N, Rizzi R, Olivieri J, Cencini E, Puccini B, Ferrarini I, Marino D, Bullo M, Rossini B, Motta M, Innocenti I, Fresa A, Stirparo L, Petrilli D, Pasquale R, Musto P, Scapinello G, Noto A, Peri V, Zamprogna G, Hohaus S, Frustaci AM, Piazza F, Ferrero S, Laurenti L. Autore F, et al. Among authors: peri v. Am J Hematol. 2025 Jan;100(1):189-191. doi: 10.1002/ajh.27524. Epub 2024 Nov 19. Am J Hematol. 2025. PMID: 39560301 No abstract available.
Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: The STRIDER study.
Dogliotti I, Peri V, Clerico M, Vassallo F, Musto D, Mercadante S, Ragaini S, Botto B, Levis M, Novo M, Ghislieri M, Molinaro L, Mortara U, Consoli C, Lonardo A, Bondielli G, Ferrero S, Freilone R, Ricardi U, Bruno B, Cavallo F. Dogliotti I, et al. Among authors: peri v. Cancer Med. 2024 Jul;13(14):e7448. doi: 10.1002/cam4.7448. Cancer Med. 2024. PMID: 39030982 Free PMC article.
SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study.
Defrancesco I, Ferretti VV, Morel P, Kyriakou C, Kastritis E, Tohidi-Esfahani I, Tedeschi A, Buske C, García-Sanz R, Vos JMI, Peri V, Margiotta Casaluci G, Ferrari A, Piazza F, Oostvogels R, Lovato E, Montes L, Fornecker LM, Grunenberg A, Dimopoulos MA, Tam CS, D'Sa S, Leblond V, Trotman J, Passamonti F, Arcaini L, Varettoni M. Defrancesco I, et al. Among authors: peri v. Hemasphere. 2023 Jun 2;7(6):e887. doi: 10.1097/HS9.0000000000000887. eCollection 2023 Jun. Hemasphere. 2023. PMID: 37283569 Free PMC article. No abstract available.
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study.
Varettoni M, Zibellini S, Merli M, Drandi D, Jiménez C, Furlan D, Ferretti VV, Fabbri N, Dogliotti I, Varraso C, Ferrante M, Cappello E, Peri V, Cavalloni C, Borriero M, Facchetti GV, Ferrero S, Arcaini L, Garcia-Sanz R. Varettoni M, et al. Among authors: peri v. Hematol Oncol. 2023 Aug;41(3):574-577. doi: 10.1002/hon.3082. Epub 2022 Oct 19. Hematol Oncol. 2023. PMID: 36218059 No abstract available.
42 results